Viewing Study NCT06361251



Ignite Creation Date: 2024-05-06 @ 8:23 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06361251
Status: RECRUITING
Last Update Posted: 2024-04-17
First Post: 2024-04-02

Brief Title: Interventional Monocentric Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots Solar and Senile Lentigines Post -Inflammatory Hyperpigmentation Pih on the Face
Sponsor: Cryonove Pharma
Organization: Cryonove Pharma

Study Overview

Official Title: Interventional Monocentric Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots Solar and Senile Lentigines Post -Inflammatory Hyperpigmentation Pih on the Face
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CS5_10
Brief Summary: The goal of this clinical trial is to compare the 2 different prototype of cytoselectivecryotherapy devices name of the devices CRYONOVE use in brown spots on the face of subject from different ethnicities The main questions it aims to answer are

the tolerance of 2 prototypes of cyto-selective cryotherapy treatments
the performance of 2 prototypes of cyto-selective cryotherapy treatments Participants will be treated for each spots with a definied prototype during 6 treatment visits

Researchers will compare the tolerance and performance of the 3 prototypes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None